rhenium has been researched along with Soft Tissue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, BT; Hsieh, JF; Lin, WY; Ting, G; Tsai, SC; Wang, SJ | 1 |
| Fukunaga, M; Kawana, M; Nakano, S; Noikura, T; Orita, K; Watanabe, K; Yamashita, S | 1 |
1 trial(s) available for rhenium and Soft Tissue Neoplasms
| Article | Year |
|---|---|
[Phase III trial of 99mTc-rhenium colloid for lymphoscintigraphy].
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Lymph Nodes; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Lymphoscintigraphy; Male; Middle Aged; Rhenium; Soft Tissue Neoplasms; Stomach Neoplasms; Technetium; Technetium Compounds | 1992 |
1 other study(ies) available for rhenium and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases.
Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Etidronic Acid; Injections, Intravenous; Isotope Labeling; Neoplasm Metastasis; Organometallic Compounds; Rabbits; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Soft Tissue Neoplasms; Tissue Distribution; Whole-Body Counting | 1999 |